Enterprise Value
578.7M
Cash
41.71M
Avg Qtr Burn
-14.93M
Short % of Float
8.47%
Insider Ownership
23.83%
Institutional Own.
71.06%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Jeuveau (prabotulinumtoxinA-xvfs) Details Glabellar lines , Benign tumor | Approved Quarterly sales |